Financial Impact of Surgical Site Infections on Hospitals
Approximately 20% of the estimated 2 million nosocomial infections in the United States each year are surgical site
infections (SSIs) that have associated costs, morbidity and mortality. While most agree about the negative clinical outcomes associated with SSIs, there is little consensus on the financial ramifications to the hospital. The objective of this study was to estimate the change in hospital profit due to SSIs.
- Scope: Approximately 20% of the estimated 2 million nosocomial infections in the US are SSIs
- Study Details: A retrospective study was performed Johns Hopkins Health Systems
- Results: Patients with an SSI compared with patients without an SSI were $58,822 vs. $35,827